openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Discover

Markets

Sinopharm Group — news, coverage & facts — IJR

|NewsJournalsOrganizationSinopharm Group

Organization

Sinopharm Group

0 members

1 mentions · 24hcoverage spread: L20/C40/R40

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Finance
Sinopec First-Half Profit Rises 12%, Fuel Prices Lift
Sinopharm Group’s interim results show revenue of about 282.8 billion yuan with net profit around 3.4 billion yuan and earnings per share of 1.09, signaling a modest profit decline amid tighter margins in its distribution business. Sinopec posted a higher first-half profit driven by stronger oil prices, but faces a cautious outlook due to downstream weakness and inventory dynamics, with analysts pointing to potential Q3 improvement and a solid dividend yield.
10 sources
Momentum
Past window
Prior window
Avg / hr

Facts from Wikidata (CC0).

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.

Overview

Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. COVID-19 Vaccine development

From Wikipedia (CC BY-SA 4.0).

Sinopharm Group across IJR

Ask IJR about Sinopharm Group Create in Studio Build a game Watch videos